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Objective To compare the outcome of two different
targeting strategies for treating radiolucent ureteric
calculi by extracorporeal shock wave lithotripsy
(ESWL), focusing the shock waves either at the end
or 5 mm beyond the column of contrast medium
visible in the ureter.
Patients and methods A total of 156 patients under-
going ESWL for a radiolucent ureteric stone were
randomized into two groups. Group 1 comprised 74
patients in whom the shock waves were focused
on the end of the contrast medium column, and
group 2 comprised 82 patients in whom the shock
waves were focused 5 mm beyond the end of the
column.
Results Both groups had comparable distributions of
age, gender, treatment methods and stone character-
istics. There were no adverse reactions to the contrast
medium. The stone-free rate after 2 months was 17%
greater in group 2 (91%) than in group 1 (74%;
P<0.05).
Conclusions The administration of intravenous contrast
medium for ESWL of radiolucent ureteric calculi is
effective and safe. We recommend that the shock
waves are focused 5 mm beyond the end of the
column of contrast medium, except where a stone
becomes clearly visible within the column.
Keywords extracorporeal shock wave lithotripsy, ureteric
stones, radiolucent, contrast medium
Introduction
Radiolucent ureteric stones can be treated effectively
with ESWL, using contrast medium to locate the
obstruction [1]. With major obstruction, the stone
would usually be expected to be apparent just below
the end of the ureteric column of contrast medium.
However, several factors may mislead the clinician when
following this assumption. With total obstruction and
a high-pressure calyceal system, the contrast medium
might be excreted and consequently reach the stone
only after a considerable delay. More importantly, with
partial but nearly complete obstruction, a small amount
of medium might pass beyond the stone, thus no longer
delineating the end of the column; the stone will then
be within the column. Contrast medium might be
absorbed in some stones, giving the same effect [2].
With the new generation of lithotripters with a high-
energy/small-focus configuration, the accurate target-
ing of the stone is essential, particularly if the stone is
not visible and the practitioner has to rely on the
indirect indications given by the ureteric column of
contrast medium.
Thus the aim of this study was to compare the out-
come of two different targeting strategies for ESWL of
radiolucent ureteric stones, directing the shock waves
at the end or 5 mm beyond the end of the contrast
medium column.
Patients and methods
Between March 1998 and December 1999, a total of
1974 stones were treated in the lithotripter unit of the
Academic Hospital Rotterdam; 884 (45%) were ureteric
and 156 of these were radiolucent. These 156 patients
were assessed for the present study; all were treated as
outpatients, under light sedation and analgesia.
We have no specific policy for acute ESWL; the stones
were diagnosed in the outpatient clinic and considered
too large to pass spontaneously (Table 1). Patients were
asked to sieve their urine until the day of treatment and
to bring any stones passed. The mean waiting time for
ESWL was 2.6 weeks. Immediately before treatment the
patient was assessed by ultrasonography for persistent
renal dilatation and an MSU taken to assess micro-
haematuria. Patients were asked about their symptoms
and stone passage. With this approach the likelihood of a
spontaneous and unnoticed stone passage was decreased,
and therefore any unnecessary ESWL minimized. An
anaesthesiologist was always present during ESWL.
In all patients the stone could not be located
with certainty and the operator relied on indirectAccepted for publication 31 May 2001
BJU International (2001), 88, 325–328
# 2001 BJU International 325
visualization, obtained by a drip infusion of 150 mL of
contrast medium, administered in the 5 min before
ESWL. In all patients the contrast medium was excreted
at a sufficient density to allow the ureter and stone to
be located. In 35 patients there was some delay until
the view was clear (f35 min). All patients were then
treated on the Lithostar Multiline1 (Siemens, Germany)
under fluoroscopic monitoring. The limits of ESWL were
a maximum of 8000 shock waves per treatment and a
maximum energy of 20 kV. All treatments were under-
taken by one operator (M.vR.) to exclude operator bias.
The patients were randomized into two groups: in
group 1 (74 patients) the shock waves were focused
directly on the end of the contrast medium column and in
group 2 (82 patients) the shock waves were focused
5 mm below the end of the column (Fig. 1). There were
slightly fewer patients in group 1, largely because some
did not attend their follow-up appointments.
During the follow-up the patients were assessed
clinically with a plain abdominal film and/or ultrasono-
graphy, IVU if there was doubt, and urine analysis at 1
and 2 months after treatment. Patients were also asked
to sieve their urine and bring any passed fragments;
these were routinely analysed by X-ray spectrography.
For these radiolucent stones, initial ultrasonography
was used to detect the resolution of any pre-existing
renal dilatation. If there was any doubt or if there was
no renal dilatation before treatment, brief IVU was used
to confirm the success of ESWL.
The results from the two groups were compared using
Student’s t-test, with P<0.05 considered to indicate
a statistically significant difference.
Results
Both groups had comparable distributions of gender
and age (Table 1); there were no statistically significant
differences in stone side, size, level and composition
(Table 1). There were no complications other than
fragment-induced colic and renal obstruction, which
required slightly more auxiliary measures and re-
treatments in group 1. However, these differences were
not statistically significant (Table 1). The mean number
and energy of the shock waves applied was not
significantly different in the two groups (Table 1). The
stone-free rate after 1 month was 54% in group 1 and
Table 1 The demographic details of the patients, the location and
size of the stones, stone composition, complications, re-treatments
and auxiliary measures, and the parameters of ESWL. None of the
differences were significant
Variable Group 1 Group 2
No of patients 74 82
Mean age, years 44.3 45.1
Men (%) 39 (52) 46 (56)
Stone characteristics
Mean size, mm2 29 31
right ureter, % 37 40
proximal, % 39 43
middle, % 22 19
distal, % 39 38
Stone composition, %
Calcium oxalate 0 0
Calcium phosphate 3 4
Uric acid 41 45
Struvite 7 5
Cystine 45 42
Others 4 4
Complications, re-treatments and auxiliary measures, %
general 0 0
contrast medium 0 0
Repeat ESWL 5 2
JJ stent 4 2
Ureterorenoscopy 3 1
Percutaneous nephrolithotomy 3 1
ESWL parameters (means)
No. of shock waves 5678 5368
Shock wave energy, kV 15.1 15.5
Fig. 1. The focal points at and beyond the end of the contrast
medium column.
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78% in group 2; after 2 months the rates were 74% and
91%, respectively, and the difference was statistically
significant.
Discussion
ESWL is the first-line treatment for most ureteric calculi;
indeed, published results are encouraging, with stone-
free rates of 79–93% [3–6]. The reported rates are lower
for the mid-ureter [3,5,6] and high in the proximal ureter
[3,6,7]. Other factors influencing success rate are stone
size, stone composition [5,8,9] and impaction [3,10].
Obesity of the patient can seriously hamper the clinical
outcome, as the depth of a stone within the surrounding
tissue can affect its localizability under ESWL [11].
Locating the stone becomes particularly difficult if
it is radiolucent; even if the lithotripter is equipped
with ultrasonography there are usually anatomical and
technical limitations making localization in the ureter
very difficult, if not impossible. However, in the very
proximal or very distal ureter this approach might be
useful. Others have proposed pushing proximal calculi
back into the renal pelvis using retrograde endoscopic
manipulation. Stones in the renal pelvis are usually more
accessible to ultrasonographic localization and ultra-
sound-guided ESWL. This approach may be helpful but
is invasive and therefore controversial [7,12]. There
remains a considerable perioperative risk associated with
this procedure. The same is true for placing a ‘pointer’
stent next to the stone [13], or undertaking routine
retrograde ureterography [14]. The easiest method for
locating the stone (although not free of risk) is the
administration of a drip infusion of intravenous contrast
medium. After a few minutes the column of medium
appears proximal to the obstruction and can indicate
the position of the stone, which appears either as a
narrowing of the ureteric calibre, or more simply as
the end of the column. Despite known adverse reac-
tions, the administration of intravenous contrast medium
is regarded as safe. The medium does not affect renal
function, even in patients with total obstruction [15].
To further decrease the risk of adverse reactions a bolus
injection can be given, rather than a drip infusion. This
requires less medium and gives more rapid opacification,
and consequently a shorter treatment time [1]. However,
in our centre the anaesthetists advised administering
the contrast medium slowly by drip infusion, to enable
them to recognize any adverse reaction in the early
stages, before the whole dose had been administered.
There were no adverse reactions in any of the 156
patients. The advantage of the current noninvasive
approach, compared with the endoscopic methods noted,
outweighs the relatively minor risk attached. None-
theless, some risk remains and thus (besides pain
management) an anaesthetist attended on stand-by in
each case.
Once the contrast medium column is apparent, only
rarely will the stone be surrounded by medium and
appear as a dark spot within the column. For most stones
the ESWL operator can only see the stone indirectly, as
a narrowing or clear end of the column. Thus the stone
can be expected either at the end of the column or just
below it. Usually the operator decides in each patient
whether to target the end of the column or just beyond it,
possibly depending on personal experience and inclina-
tion. The present study is the first objective assessment
of the best targeting strategy for radiolucent stones
that are not clearly visible within a column of contrast
medium. The patients were comparable with those
reported by others [3–8,10,16]; the results showed a
clear and statistically significant advantage, with a 17%
greater stone-free rate for patients in group 2. However,
74% of patients in group 1 also became stone-free
within 2 months; considering that the present lithotripter
had a relatively small focus of 5r9 mm, many stones
must have been partially engulfed by the contrast
medium, or had absorbed it.
Admittedly, respiratory movements in the longitudi-
nal axis might also have partially annulled the dis-
advantage of the small focus, but this would have led
to overlaps in both groups and thus cancelled the effect.
In any case, the focus of the machine is routinely targeted
in the phase between inspiration and expiration, thus
minimizing the breathing error.
As a tertiary referral centre we treat many patients
with cystine stones (Table 1); thus we have an extensive
experience with these stones and usually try to treat
most of them with ESWL, initially set at the highest
permissible intensity. Such stones are hard and shock-
wave resistant, but as ureteric stones can be exposed
to more shock waves and at a higher intensity than
can kidney stones, the cystine stones were treated
successfully in most cases.
In conclusion, the administration of intravenous
contrast medium for targeting radiolucent ureteric
calculi during ESWL is easy, noninvasive and safe.
Adverse reactions are rare, but caution is mandatory.
When the column of contrast medium appears proximal
to the stone we recommend focusing 5 mm beyond
the end of the column except when the stone is clearly
visible within the column.
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